Advisor Group Holdings, Inc. Genfit S.A. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Genfit S.A. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 250 shares of GNFT stock, worth $1,125. This represents 0.0% of its overall portfolio holdings.

Number of Shares

250

Previous 273 8.42%

Holding current value

$1,125

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.92 - $5.97 $90 - $137	-23 Reduced 8.42%	250 $1,000
Q2 2024 Aug 13, 2024	BUY	$3.41 - $5.92 $930 - $1,616	273 New	273 $0
Q2 2023 Aug 10, 2023	BUY	$3.54 - $4.68 $63 - $84	18 New	18 $0
Q1 2021 May 13, 2021	SELL	$4.53 - $6.06 $58 - $78	-13 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.2 - $22.0 $6,172 - $26,114	-1,187 Reduced 98.92%	13 $0
Q1 2020 May 18, 2020	BUY	$10.95 - $20.76 $13,140 - $24,912	1,200 New	1,200 $18,000

Others Institutions Holding GNFT

# of Institutions

Shares Held

77.7K

Call Options Held

Put Options Held

View Full List

About Genfit S.A.

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $224M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

More about GNFT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Genfit S.A. Transaction History